Susquehanna International Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5M Sell
104,600
-50,000
-32% -$9.71M ﹤0.01% 2196
2025
Q4
$26.8M Sell
154,600
-50,100
-24% -$9.12M ﹤0.01% 1920
2025
Q3
$39M Buy
204,700
+41,000
+25% +$7.28M ﹤0.01% 1539
2025
Q2
$29.4M Buy
163,700
+58,300
+55% +$10.1M ﹤0.01% 1629
2025
Q1
$17.8M Buy
105,400
+7,600
+8% +$1.25M ﹤0.01% 1849
2024
Q4
$14.8M Buy
97,800
+7,800
+9% +$1.21M ﹤0.01% 2185
2024
Q3
$14M Sell
90,000
-28,400
-24% -$4.24M ﹤0.01% 2195
2024
Q2
$16.2M Sell
118,400
-121,900
-51% -$16.7M ﹤0.01% 1959
2024
Q1
$32M Buy
240,300
+27,100
+13% +$3.52M 0.01% 1355
2023
Q4
$29.4M Sell
213,200
-28,700
-12% -$3.77M 0.01% 1432
2023
Q3
$29.5M Buy
241,900
+112,200
+87% +$14.9M 0.01% 1401
2023
Q2
$18.2M Buy
129,700
+22,500
+21% +$3.1M ﹤0.01% 1820
2023
Q1
$15.2M Sell
107,200
-116,700
-52% -$16.7M ﹤0.01% 1976
2022
Q4
$35M Buy
223,900
+154,400
+222% +$22.2M 0.01% 1092
2022
Q3
$8.53M Sell
69,500
-88,900
-56% -$11.7M ﹤0.01% 2389
2022
Q2
$21.1M Buy
158,400
+41,600
+36% +$5.67M 0.01% 1413
2022
Q1
$16M Sell
116,800
-64,500
-36% -$8.99M ﹤0.01% 1951
2021
Q4
$31.4M Sell
181,300
-14,400
-7% -$2.19M ﹤0.01% 1432
2021
Q3
$28.4M Sell
195,700
-6,200
-3% -$907K ﹤0.01% 1643
2021
Q2
$26.6M Buy
201,900
+96,600
+92% +$12.6M ﹤0.01% 1724
2021
Q1
$13.5M Sell
105,300
-12,800
-11% -$1.58M ﹤0.01% 2357
2020
Q4
$14.1M Sell
118,100
-28,500
-19% -$3.47M ﹤0.01% 2105
2020
Q3
$16.8M Sell
146,600
-800
-0.5% -$94.5K ﹤0.01% 1649
2020
Q2
$16.8M Buy
147,400
+8,100
+6% +$859K ﹤0.01% 1591
2020
Q1
$11.2M Sell
139,300
-18,600
-12% -$1.93M ﹤0.01% 1623
2019
Q4
$16.9M Sell
157,900
-53,600
-25% -$5.59M ﹤0.01% 1577
2019
Q3
$22.6M Buy
211,500
+93,900
+80% +$9.64M 0.01% 1242
2019
Q2
$12M Buy
117,600
+69,500
+144% +$6.68M ﹤0.01% 1720
2019
Q1
$4.33M Sell
48,100
-47,400
-50% -$4.11M ﹤0.01% 2630
2018
Q4
$7.95M Sell
95,500
-30,800
-24% -$2.89M ﹤0.01% 1818
2018
Q3
$13.6M Sell
126,300
-60,600
-32% -$6.65M ﹤0.01% 1651
2018
Q2
$20.5M Sell
186,900
-8,000
-4% -$833K 0.01% 1278
2018
Q1
$19.5M Buy
194,900
+168,900
+650% +$17.3M 0.01% 1227
2017
Q4
$2.56M Sell
26,000
-26,600
-51% -$2.52M ﹤0.01% 3488
2017
Q3
$4.92M Buy
52,600
+26,900
+105% +$2.86M ﹤0.01% 2517
2017
Q2
$2.86M Sell
25,700
-21,700
-46% -$2.29M ﹤0.01% 3249
2017
Q1
$4.65M Sell
47,400
-10,600
-18% -$1.01M ﹤0.01% 2446
2016
Q4
$5.33M Buy
58,000
+17,700
+44% +$1.53M ﹤0.01% 2322
2016
Q3
$3.41M Buy
40,300
+12,200
+43% +$1.02M ﹤0.01% 2727
2016
Q2
$2.29M Sell
28,100
-137,700
-83% -$10.5M ﹤0.01% 3352
2016
Q1
$11.8M Buy
165,800
+9,000
+6% +$604K 0.01% 1397
2015
Q4
$11.2M Buy
156,800
+28,800
+23% +$1.94M 0.01% 1654
2015
Q3
$7.87M Sell
128,000
-169,000
-57% -$11.8M ﹤0.01% 2104
2015
Q2
$21.5M Buy
297,000
+67,700
+30% +$5M 0.01% 1245
2015
Q1
$17.6M Sell
229,300
-247,900
-52% -$17.8M 0.01% 1330
2014
Q4
$32M Buy
477,200
+49,200
+11% +$3.1M 0.01% 993
2014
Q3
$26M Sell
428,000
-36,500
-8% -$2.25M 0.01% 1181
2014
Q2
$27.3M Buy
464,500
+104,500
+29% +$6.12M 0.01% 1123
2014
Q1
$20.9M Buy
360,000
+167,200
+87% +$8.96M 0.01% 1238
2013
Q4
$10.3M Buy
192,800
+54,500
+39% +$3.23M ﹤0.01% 2028
2013
Q3
$8.55M Buy
138,300
+48,500
+54% +$2.9M ﹤0.01% 2062
2013
Q2
$5.45M Buy
+89,800
New +$5.35M ﹤0.01% 2508

Other funds holding DGX

Susquehanna International Group's DGX Position: Q1 2026 in Review

Susquehanna International Group reduced its Quest Diagnostics (DGX) stake by 40% in Q1 2026, selling an estimated $2.35M and leaving 18,519 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4865.

Susquehanna International Group first reported a position in DGX in Q2 2013 and has held it in 47 quarters since. The position peaked at $11.9M in Q3 2013. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Susquehanna International Group held 18,519 shares of Quest Diagnostics worth $3.63M as of Q1 2026.
  • Susquehanna International Group sold 12,109 Quest Diagnostics shares in Q1 2026, an estimated $2.35M.
  • Quest Diagnostics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4865 holding.
  • Susquehanna International Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Quest Diagnostics position peaked at $11.9M in Q3 2013.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.